I think this company has a bright future.
Could some one answer this for me, on the EchoIQ website it says:
*EchoSolv™ phenotyping capabilities are available in New Zealand, with regulatory clearance planned for the US and Australia regions
So how many cardiologists, hospitals etc are using this in NZ?
Are we generating any revenue from NZ?
Ann: Echo IQ Webinar 27 May 2024 - Recording Available, page-4
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.64M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $11.80K | 78.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 178000 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 41526 | 1 |
View Market Depth
| Last trade - 15.58pm 19/07/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |